Earflo

About Earflo

Earflo is a company focused on providing innovative medical solutions for children with negative middle ear pressure. Their mission is to offer a non-invasive, at-home treatment to prevent hearing loss, reduce pain, and improve quality of life by avoiding surgical interventions.

Products & Services

Earflo Device:A child-friendly medical device designed like a sippy cup to treat negative middle ear pressure in children as young as two. It helps open the eustachian tube through a gentle air push during swallowing, relieving pressure and preventing hearing loss. The device is accompanied by a companion app to make treatment enjoyable.

Specialties

Pediatric Ear Health Non-Invasive Treatment Biomedical Engineering ENT Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Social-Mission Investment T: - FT: Social-Mission Investment	A: 415000 MR: - FA: $415,000 FAN: 415000	D: 2025-11-19 FD: 2025-11-19	1 investors

Social-Mission Investment Latest

2025-11-19

$415K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Soto MJ

Biomedical Engineer

H

Hura N

O

Oldakowska I

I

Intan Oldakowska

Biomedical Engineer and Entrepreneur

O

Oldakowski M

B

Bumbak P

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Earflo Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised